Skip to Main Content

The Philips respiratory machine recall is a no-win situation for patients and doctors. But for the medical device giant’s longtime rivals and new competitors, business is looking up.

“We think it will be difficult for Philips to regain all the share that they had,” said Margaret Kaczor, an analyst with William Blair who follows ResMed among other companies. “This is an advantage for ResMed to the extent they can keep the share that they’ve gained.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment